4th Quarter - Report
DENDREON PHARMACEUTICALS, LLC for DENDREON PHARMACEUTICALS, LLC
Income
—
Expenses
$102,185
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Access to autologous cellular immunotherapies in Medicare Part B. Provisions included in Title I - Subtitle B of PL. 117-169/H.R. 5376 - Inflation Reduction Act of 2022. Monitoring the FY 2023 Appropriations and FY 2022 Reconciliation Process.
Foreign entity interest: Dendreon, a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW SAELENS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.